[Primary cutaneous B-cell lymphoma: present views]

F Fakan1

  • 1Siklův patologicko-anatomický ústav LF UK, Plzen.

Ceskoslovenska Patologie
|September 29, 1998
PubMed

Insights

Most cutaneous B-cell lymphomas are primary skin lymphomas, not spread from elsewhere. These primary cutaneous B-cell lymphomas, including newly defined types, generally respond well to treatment and have a good prognosis.

Area of Science:

  • Dermatology
  • Hematology
  • Oncology

Context:

  • Cutaneous B-cell lymphomas (CBCLs) are a heterogeneous group of malignant neoplasms.
  • Distinguishing primary CBCLs from secondary involvement or pseudolymphoma is crucial for accurate diagnosis and management.
  • Recent advancements have led to the definition of new entities within CBCL classification.

Purpose:

  • To describe the evolution of classification systems for primary cutaneous B-cell lymphomas.
  • To highlight newly defined entities such as primary cutaneous marginal zone B-cell lymphoma, primary cutaneous follicular centre cell lymphoma, and large B-cell lymphoma of the legs.
  • To provide an overview of the diagnostic criteria and clinical significance of these lymphomas.

Summary:

  • The majority of lymphoproliferative B-cell cutaneous lesions are confirmed as primary lymphomas of the skin.
  • The classification of primary cutaneous B-cell lymphomas has been refined, incorporating newly identified subtypes.
  • Key entities discussed include primary cutaneous marginal zone B-cell lymphoma, primary cutaneous follicular centre cell lymphoma, and leg-type large B-cell lymphoma.

Impact:

  • Accurate classification improves diagnostic precision for cutaneous B-cell lymphomas.
  • Understanding newly defined entities aids in tailored treatment strategies.
  • Most primary cutaneous B-cell lymphomas exhibit a favorable response to therapy and a good prognosis, offering hope for affected patients.